EssilorLuxottica (OTCMKTS:ESLOY) Shares Up 5.6% – What’s Next?

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY)’s stock price shot up 5.6% on Wednesday. The stock traded as high as $97.03 and last traded at $97.03. 14,054 shares changed hands during trading, a decline of 90% from the average session volume of 138,710 shares. The stock had previously closed at $91.90.

Analyst Upgrades and Downgrades

ESLOY has been the subject of several research analyst reports. Kepler Capital Markets cut shares of EssilorLuxottica from a “strong-buy” rating to a “strong sell” rating in a report on Thursday, September 17th. Zacks Research raised shares of EssilorLuxottica from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. The Goldman Sachs Group downgraded shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Citigroup reaffirmed a “buy” rating on shares of EssilorLuxottica in a report on Monday. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of EssilorLuxottica in a report on Tuesday, September 22nd. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy”.

EssilorLuxottica Stock Performance

The company has a 50 day simple moving average of $86.83 and a 200 day simple moving average of $97.02.

EssilorLuxottica Company Profile

EssilorLuxottica is a global company specializing in the design, manufacture and distribution of ophthalmic lenses, eyewear and related optical products. Its activities span the value chain, including lens technology, prescription frames, sunglasses, retail, wholesale distribution and vision-care services.

The company’s portfolio includes well-known eyewear brands such as Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear and Costa. Its lens and vision-care brands include Varilux, Crizal, Transitions and Eyezen.